3 Reasons SHC is Risky and 1 Stock to Buy Instead
Is Sotera Health Company (SHC) A Good Stock To Buy Now?
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Goldman Sachs Initiates Coverage On Sotera Health with Buy Rating, Announces Price Target of $20
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
The Bull Case For Sotera Health (SHC) Could Change Following Term Loan Refinancing At Lower Interest Margin
A Look At Sotera Health (SHC) Valuation After Strong Q1 Beat And Upgraded Full Year Outlook
Q1 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks
3 Stocks Under $50 We Find Risky
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Find Risky
5 Revealing Analyst Questions From Sotera Health Company’s Q1 Earnings Call
Sotera Health's (NASDAQ:SHC) Solid Earnings Are Supported By Other Strong Factors
Sotera Health Announces Secondary Offering of Common Stock
A Look At Sotera Health (SHC) Valuation As Shares Trade Below Analyst Fair Value Estimates
Sotera Health Commences 31.8M Common Stock Offering On Behalf Of Selling Shareholders
Sotera Health Company 2026 Q1 - Results - Earnings Call Presentation
Why Broyhill May Be Buying More Sotera Health Shares
Piper Sandler Reiterates Overweight on Sotera Health, Lowers Price Target to $22
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.